MEDAVAIL HOLDINGS INC's ticker is MDVL and the CUSIP is 58406B103. A total of 51 filers reported holding MEDAVAIL HOLDINGS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $205,057 | -14.5% | 836,626 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $239,777 | -4.4% | 836,626 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $250,820 | -61.4% | 836,626 | 0.0% | 0.01% | -61.5% |
| Q3 2022 | $649,000 | -49.3% | 836,626 | 0.0% | 0.01% | -50.0% |
| Q2 2022 | $1,280,000 | +15.3% | 836,626 | -26.8% | 0.03% | +4.0% |
| Q1 2022 | $1,110,000 | -30.6% | 1,142,552 | 0.0% | 0.02% | -26.5% |
| Q4 2021 | $1,600,000 | -52.0% | 1,142,552 | 0.0% | 0.03% | -47.7% |
| Q3 2021 | $3,336,000 | -76.2% | 1,142,552 | 0.0% | 0.06% | -73.9% |
| Q2 2021 | $13,996,000 | -12.5% | 1,142,552 | 0.0% | 0.25% | -25.9% |
| Q1 2021 | $15,996,000 | -7.0% | 1,142,552 | 0.0% | 0.34% | -1.2% |
| Q4 2020 | $17,195,000 | – | 1,142,552 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 15,029,480 | $3,683,726 | 66.84% |
| Ally Bridge Group (NY) LLC | 5,894,897 | $1,444,839 | 1.75% |
| Redmile Group, LLC | 34,604,516 | $8,481,567 | 0.33% |
| Alyeska Investment Group, L.P. | 3,113,325 | $38,153,798 | 0.28% |
| CIGNA INVESTMENTS INC /NEW | 2,389,478 | $586 | 0.11% |
| Alyeska Investment Group, L.P. | 6,015,043 | $1,474,287 | 0.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 836,626 | $205,057 | 0.00% |
| PURA VIDA INVESTMENTS, LLC | 58,070 | $18,829 | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $245,100 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |